Stock Scorecard
Stock Summary for MaxCyte Inc (MXCT) - $1.17 as of 6/29/2026 8:45:28 AM EST
Total Score
11 out of 30
Safety Score
22 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for MXCT
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for MXCT
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for MXCT
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for MXCT
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for MXCT (22 out of 100)
| Stock Price Rating (Max of 10) | 2 |
| Historical Stock Price Rating (Max of 10) | 4 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 2 |
| Book Value to Price (Max of 10) | 8 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Latest News for for MXCT
Financial Details for MXCT
Company Overview |
|
|---|---|
| Ticker | MXCT |
| Company Name | MaxCyte Inc |
| Country | N/A |
| Description | MaxCyte Inc. (MXCT) is a leader in cell-engineering, renowned for its innovative Flow Electroporation® technology that enables efficient and scalable delivery of nucleic acids and proteins into a variety of cell types. The company serves a prestigious clientele, including top biopharmaceutical firms and research institutions, positioning it favorably within the rapidly expanding cell and gene therapy market. MaxCyte's advanced platforms play a crucial role in the development of novel cell-based therapies and vaccines, responding to the growing global demand for transformative healthcare solutions. With a steadfast commitment to enhancing patient outcomes, MaxCyte is poised to capitalize on significant market opportunities in the life sciences sector. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL DEVICES |
| Most Recent Quarter | 3/31/2026 |
| Next Earnings Date | 8/5/2026 |
Stock Price History |
|
| Last Day Price | 1.17 |
| Price 4 Years Ago | 5.46 |
| Last Day Price Updated | 6/29/2026 8:45:28 AM EST |
| Last Day Volume | 13,155,917 |
| Average Daily Volume | 1,461,612 |
| 52-Week High | 2.37 |
| 52-Week Low | 0.64 |
| Last Price to 52 Week Low | 82.81% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 31.54 |
| Sector PE | 77.87 |
| 5-Year Average PE | -13.37 |
| Free Cash Flow Ratio | 8.36 |
| Industry Free Cash Flow Ratio | 39.07 |
| Sector Free Cash Flow Ratio | 34.98 |
| Current Ratio Most Recent Quarter | 12.04 |
| Total Cash Per Share | 0.14 |
| Book Value Per Share Most Recent Quarter | 1.57 |
| Price to Book Ratio | 0.76 |
| Industry Price to Book Ratio | 5.74 |
| Sector Price to Book Ratio | 12.80 |
| Price to Sales Ratio Twelve Trailing Months | 4.23 |
| Industry Price to Sales Ratio Twelve Trailing Months | 3.43 |
| Sector Price to Sales Ratio Twelve Trailing Months | 32.76 |
| Analyst Buy Ratings | 5 |
| Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
| Total Shares Outstanding | 107,122,000 |
| Market Capitalization | 125,332,740 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -8.71% |
| Reported EPS 12 Trailing Months | -0.36 |
| Reported EPS Past Year | -0.04 |
| Reported EPS Prior Year | -0.40 |
| Net Income Twelve Trailing Months | -39,119,000 |
| Net Income Past Year | -44,630,000 |
| Net Income Prior Year | -41,055,000 |
| Quarterly Revenue Growth YOY | -7.10% |
| 5-Year Revenue Growth | 4.76% |
| Operating Margin Twelve Trailing Months | -64.10% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 14,557,000 |
| Total Cash Past Year | 20,065,000 |
| Total Cash Prior Year | 27,884,000 |
| Net Cash Position Most Recent Quarter | 14,557,000 |
| Net Cash Position Past Year | 15,148,000 |
| Long Term Debt Past Year | 4,917,000 |
| Long Term Debt Prior Year | 4,917,000 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 0.97 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 171,490,000 |
| Total Stockholder Equity Prior Year | 206,251,000 |
| Total Stockholder Equity Most Recent Quarter | 167,886,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -29,505,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.28 |
| Free Cash Flow Past Year | -36,178,000 |
| Free Cash Flow Prior Year | -29,261,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.09 |
| MACD Signal | 0.07 |
| 20-Day Bollinger Lower Band | 0.57 |
| 20-Day Bollinger Middle Band | 0.89 |
| 20-Day Bollinger Upper Band | 1.20 |
| Beta | 1.67 |
| RSI | 67.80 |
| 50-Day SMA | 1.35 |
| 150-Day SMA | 3.06 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 6/27/2026 4:19:06 AM EST |